Literature DB >> 25312956

Transgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 response.

Steve Oghumu1, James C Stock2, Sanjay Varikuti2, Ran Dong3, Cesar Terrazas2, Jessica A Edwards4, Chad A Rappleye4, Ariel Holovatyk2, Arlene Sharpe5, Abhay R Satoskar6.   

Abstract

Cutaneous leishmaniasis, caused mainly by Leishmania major, an obligate intracellular parasite, is a disfiguring disease characterized by large skin lesions and is transmitted by a sand fly vector. We previously showed that the chemokine receptor CXCR3 plays a critical role in mediating resistance to cutaneous leishmaniasis caused by Leishmania major. Furthermore, T cells from L. major-susceptible BALB/c but not L. major-resistant C57BL/6 mice fail to efficiently upregulate CXCR3 upon activation. We therefore examined whether transgenic expression of CXCR3 on T cells would enhance resistance to L. major infection in susceptible BALB/c mice. We generated BALB/c and C57BL/6 transgenic mice, which constitutively overexpressed CXCR3 under a CD2 promoter, and then examined the outcomes with L. major infection. Contrary to our hypothesis, transgenic expression of CXCR3 (CXCR3(Tg)) on T cells of BALB/c mice resulted in increased lesion sizes and parasite burdens compared to wild-type (WT) littermates after L. major infection. Restimulated lymph node cells from L. major-infected BALB/c-CXCR3(Tg) mice produced more interleukin-4 (IL-4) and IL-10 and less gamma interferon (IFN-γ). Cells in draining lymph nodes from BALB/c-CXCR3(Tg) mice showed enhanced Th2 and reduced Th1 cell accumulation associated with increased neutrophils and inflammatory monocytes. However, monocytes displayed an immature phenotype which correlated with increased parasite burdens. Interestingly, transgenic expression of CXCR3 on T cells did not impact the outcome of L. major infection in C57BL/6 mice, which mounted a predominantly Th1 response and spontaneously resolved their infection similar to WT littermates. Our findings demonstrate that transgenic expression of CXCR3 on T cells increases susceptibility of BALB/c mice to L. major.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25312956      PMCID: PMC4288897          DOI: 10.1128/IAI.02540-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  T cells from Leishmania major-susceptible BALB/c mice have a defect in efficiently up-regulating CXCR3 upon activation.

Authors:  Joseph Barbi; Frank Brombacher; Abhay R Satoskar
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 2.  Role of chemokines in regulation of immunity against leishmaniasis.

Authors:  Steve Oghumu; Claudio M Lezama-Dávila; Angelica P Isaac-Márquez; Abhay R Satoskar
Journal:  Exp Parasitol       Date:  2010-03-03       Impact factor: 2.011

3.  An immunomodulatory function for neutrophils during the induction of a CD4+ Th2 response in BALB/c mice infected with Leishmania major.

Authors:  F Tacchini-Cottier; C Zweifel; Y Belkaid; C Mukankundiye; M Vasei; P Launois; G Milon; J A Louis
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

4.  CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses.

Authors:  Jing Zhou; Paul C Y Tang; Lingfeng Qin; Peter M Gayed; Wei Li; Eleni A Skokos; Themis R Kyriakides; Jordan S Pober; George Tellides
Journal:  J Exp Med       Date:  2010-08-23       Impact factor: 14.307

5.  Are neutrophils important host cells for Leishmania parasites?

Authors:  Uwe Ritter; Freddy Frischknecht; Ger van Zandbergen
Journal:  Trends Parasitol       Date:  2009-09-15

6.  CD4+ T-cell development in a mouse expressing a transgenic TCR derived from a Treg.

Authors:  Richard J DiPaolo; Ethan M Shevach
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

7.  Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo.

Authors:  R G Jones; M Parsons; M Bonnard; V S Chan; W C Yeh; J R Woodgett; P S Ohashi
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

8.  T helper type 2 cell differentiation occurs in the presence of interleukin 12 receptor beta2 chain expression and signaling.

Authors:  R Nishikomori; R O Ehrhardt; W Strober
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

9.  Innate immunity to Leishmania infection: within phagocytes.

Authors:  Marcela Freitas Lopes; Ana Caroline Costa-da-Silva; George Alexandre DosReis
Journal:  Mediators Inflamm       Date:  2014-07-07       Impact factor: 4.711

10.  Transgenic Bcl-3 slows T cell proliferation.

Authors:  Michael F J Bassetti; Janice White; John W Kappler; Philippa Marrack
Journal:  Int Immunol       Date:  2009-02-10       Impact factor: 4.823

View more
  4 in total

1.  Transgenic T cell-specific expression of CXCR3 enhances splenic and hepatic T cell accumulation but does not affect the outcome of visceral leishmaniasis.

Authors:  Sanjay Varikuti; Gayathri Natarajan; Steve Oghumu; Rachel H Sperling; Ellen Moretti; James Stock; Tracey L Papenfuss; Abhay R Satoskar
Journal:  Cell Immunol       Date:  2016-09-06       Impact factor: 4.868

2.  MicroRNA155 Plays a Critical Role in the Pathogenesis of Cutaneous Leishmania major Infection by Promoting a Th2 Response and Attenuating Dendritic Cell Activity.

Authors:  Sanjay Varikuti; Chaitenya Verma; Gayathri Natarajan; Steve Oghumu; Abhay R Satoskar
Journal:  Am J Pathol       Date:  2021-02-02       Impact factor: 4.307

3.  Evaluation of IL-12RB1, IL-12B, CXCR-3 and IL-17a expression in cases affected by a non-healing form of cutaneous leishmaniasis: an observational study design.

Authors:  Mohammad Moafi; Hossein Rezvan; Roya Sherkat; Roya Taleban; Ali Asilian; Seyed Hamid Zarkesh Esfahani; Mohammad Ali Nilforoushzadeh; Fariba Jaffary; Awat Feizi
Journal:  BMJ Open       Date:  2017-01-27       Impact factor: 2.692

Review 4.  The IL-33/ST2 Axis in Immune Responses Against Parasitic Disease: Potential Therapeutic Applications.

Authors:  Nathan Ryan; Kelvin Anderson; Greta Volpedo; Sanjay Varikuti; Monika Satoskar; Sanika Satoskar; Steve Oghumu
Journal:  Front Cell Infect Microbiol       Date:  2020-04-17       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.